BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.38
+0.08 (0.86%)
At close: Aug 7, 2026, 4:00 PM EDT
9.42
+0.04 (0.43%)
After-hours: Aug 7, 2026, 7:51 PM EDT

BioCryst Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
154.9789.74104.71110.64304.77504.39
Short-Term Investments
197.6185.01216.14278.34119.543.21
Cash & Short-Term Investments
352.57274.75320.85388.99424.31507.6
Cash Growth
35.59%-14.37%-17.52%-8.33%-16.41%68.99%
Accounts Receivable
110.76106.8279.0756.9550.629.41
Inventory
6.065.48.0928.6827.5315.79
Other Current Assets
15.317.3813.9621.3514.0613.33
Total Current Assets
484.68404.35421.97495.97516.5566.14
Net Property, Plant & Equipment
21.6718.9919.7920.918.628.71
Long-Term Investments
-61.1620.32-18.086.83
Other Long-Term Assets
51.529.6628.340.086.816.47
Total Assets
557.85514.16490.42516.96550588.15
Accounts Payable
11.4615.8311.6420.8914.3627.81
Accrued Expenses
121.9126.41113.29102.8887.5772.67
Short-Term Debt
43.8138.4632.6823.57--
Current Portion of Leases
15.321.632.772.653.593.24
Unearned Revenue
12.32---1.221.42
Other Current Liabilities
16.3613.74----
Total Current Liabilities
208.85196.07160.38149.99105.51103.72
Long-Term Debt
778.38427.23795.92811.27733.28585.46
Long-Term Leases
11.4510.0110.0511.245.85.96
Other Long-Term Liabilities
13.46-----
Total Long-Term Liabilities
803.29437.25805.97822.5739.08591.42
Total Liabilities
1,012633.31966.35972.49844.6695.14
Common Stock
2.552.132.092.061.881.84
Additional Paid-in Capital
1,6931,3851,2911,2221,1581,098
Accumulated Other Comprehensive Income
-0.530.040.921.340.030.18
Retained Earnings
-2,150-1,506-1,770-1,681-1,455-1,208
Shareholders' Equity
-454.29-119.15-475.93-455.53-294.6-106.99
Total Liabilities & Equity
557.85514.16490.42516.96550588.15
Total Debt
848.97477.33841.42848.71742.68594.66
Net Cash (Debt)
-496.39-202.58-520.57-459.73-318.37-87.06
Net Cash Growth
------
Net Cash Per Share
-2.10-0.93-2.52-2.39-1.71-0.49
Book Value
-454.29-119.15-475.93-455.53-294.6-106.99
Book Value Per Share
-1.92-0.55-2.30-2.37-1.58-0.60
Tangible Book Value
-454.29-119.15-475.93-455.53-294.6-106.99
Tangible Book Value Per Share
-1.92-0.55-2.30-2.37-1.58-0.60
SEC Filings: 10-K · 10-Q